Literature DB >> 34009660

In vitro activity of lactoferricin solution against Malassezia pachydermatis from otitis externa in dogs and cats.

Antonio Corona1, Antonella Vercelli1, Natascia Bruni2, Eleonora Guidi1, Luisa Cornegliani1.   

Abstract

BACKGROUND: Malassezia pachydermatis is a commensal organism of the skin, yet it may induce dermatitis and/or otitis. Lactoferricin (Lfcin) is an antimicrobial peptide obtained by the pepsin-mediated digestion of lactoferrin, a multifunctional innate-defence milk protein. The antibacterial activity of Lfcin is thought to cause alteration of bacterial membrane permeability, thus inducing cell death.
OBJECTIVES: The aim of this study was to evaluate in vitro antifungal activity of different dilutions of Lfcin solution against M. pachydermatis strains isolated from ears of dogs and cats with otitis externa. METHODS AND MATERIALS: Fifty clinical Malassezia isolates from 40 dogs and 10 cats were tested. A dilution method in microtitre plates was used starting with a 20% Lfcin water solution. The different dilutions were 2:1 (13.3%), 1:1 (10%), 1:2 (6.7%), 1:5 (3.3%) and 1:10 (1.8%). Results were expressed as the value at which the growth of 50% (minimal fungicidal concentration MFC50 ) and 90% (MFC90 ) of yeast cells was inhibited.
RESULTS: All strains showed susceptibility to 20% Lfcin solution (100%). With 1:5 and 1:10 dilutions corresponding to 3.3% and 1.8% Lfcin solutions, all strains showed resistance. The MFC50 and MFC90 values were observed at 13.3% and 20% Lfcin solutions. CONCLUSIONS AND CLINICAL RELEVANCE: The results indicated that Lfcin solution exhibits the antimicrobial activity specific to antimicrobial peptides. In particular, the 20% solution can be effective in killing M. pachydermatis isolated strains. Some susceptibilities also are evident at lower concentrations of ≤6.7% for four strains.
© 2021 the European Society of Veterinary Dermatology and the American College of Veterinary Dermatology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34009660     DOI: 10.1111/vde.12973

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  1 in total

1.  Antimicrobial Mechanisms of Enterocin CHQS Against Candida albicans.

Authors:  Qi Wang; Lei Pan; Ye Han; Zhijiang Zhou
Journal:  Curr Microbiol       Date:  2022-05-13       Impact factor: 2.188

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.